RecruitingNot Applicable

Acupuncture Therapy and Hypertension

United States72 participantsStarted 2023-01-01

Plain-language summary

Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.

Who can participate

Age range45 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects from 45 to 75 years of age
✓. Clinically diagnosed with mild to moderate hypertension and ON or OFF medication (Office SBP \> 140 mmHg and \< 160 mmHg Or ABPM average SBP \> 130 mmHg and \< 145 mmHg), and
✓. No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study.

Exclusion criteria

✕. Subjects will be excluded if pregnant or nursing.
✕. Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (\<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP \>170 mmHg systolic or \>110 mmHg diastolic), or any other physical or psychological illness.
✕. Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded.
✕. Inability our or unwillingness of individual to give written informed consent.

What they're measuring

Changes in sympathetic and parasympathetic nervous systems

Timeframe: through study completion, an average of 4.5 years

Trial details

NCT IDNCT05530512

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-31

Contact for this trial

Ashwini Erande

7144567025 aerande@hs.uci.edu

View on ClinicalTrials.gov More Mild to Moderate Hypertension trials